FDA Inspection
Seqirus IncSeqirus Inc – FDA Inspection, Jun 18, 2018
Record Details
This FDA Inspection record concerns Seqirus Inc, with an inspection on June 18, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 4027549a-c56f-482f-8f8f-d3fe1419260f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1061837
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Seqirus Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 5, 2025 | VAI | Atlanta District Office | Vaccine, Allergenic, and Live Biotherapeutic Products |
| June 9, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 17, 2016 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 21, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Seqirus Inc
- FDA Inspection 1271769 - 2025-06-05
- FDA Inspection 1172982 - 2022-06-09
- FDA Inspection 968013 - 2016-05-17
- FDA Inspection 860576 - 2013-11-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.